Science 37 to Present at the Baird 2022 Global Healthcare Conference
Science 37 Holdings, Inc. (Nasdaq: SNCE) announced its participation in the Baird Global Healthcare Conference in New York, scheduled for September 13, 2022, at 3:45 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Science 37 Holdings, Inc. (Nasdaq: SNCE) announced its participation in the Baird Global Healthcare Conference in New York, scheduled for September 13, 2022, at 3:45 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the company's Investor Relations webpage.
Science 37 aims to improve access to clinical research through its Agile Clinical Trial Operating System™, enhancing the speed and diversity of patient enrollment while supporting decentralized clinical trials.
Details
News Market Reaction – SNCE
The recorded move for SNCE in the trading session of this news was +2.76%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York.
Science 37’s management is scheduled to present on Tuesday, September 13, 2022, at 3:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://investors.science37.com.
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment,
MEDIA INQUIRIES
Drew Bustos
Science 37
Phone: (984) 377-3737
Email: pr@science37.com
INVESTOR RELATIONS:
Caroline Paul
Gilmartin Group
Investors@science37.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.